Ensysce Biosciences (ENSCW) Shares Outstanding (Weighted Average) (2017 - 2025)

Ensysce Biosciences (ENSCW) has 9 years of Shares Outstanding (Weighted Average) data on file, last reported at $2.6 million in Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $2.6 million, up 266.55% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.6 million (up 266.55% YoY), and the FY2025 annual result was $2.6 million, up 266.55% from the prior year.
• Shares Outstanding (Weighted Average) slipped to $2.6 million in Q4 2025 per ENSCW's latest filing, from $2.9 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $16.1 million in Q2 2021 and troughed at $113696.0 in Q1 2022.
• A 5-year average of $2.5 million and a median of $972995.5 in 2021 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) plunged 99.28% in 2022, then surged 827.21% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.0 million in 2021, then plunged by 82.15% to $179925.0 in 2022, then declined by 16.11% to $150937.0 in 2023, then surged by 362.24% to $697686.0 in 2024, then jumped by 266.55% to $2.6 million in 2025.
• Business Quant data shows ENSCW's Shares Outstanding (Weighted Average) at $2.6 million in Q4 2025, $2.9 million in Q3 2025, and $2.2 million in Q2 2025.